Anti-QKI antibody [EPR7306]
- RabMAb
- Recombinant
- KO Validated
- 20ul selling size
- What is this?
4
(2 Reviews)
|
(30 Publications)
Rabbit Recombinant Monoclonal QKI antibody. Suitable for IP, WB, ICC/IF and reacts with Human, Mouse samples. Cited in 30 publications.
View Alternative Names
HKQ, QKI, KH domain-containing RNA-binding protein QKI, Protein quaking, Hqk, HqkI
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-QKI antibody [EPR7306] (AB126742)
Immunocytochemistry/ Immunofluorescence analysis of Neuro-2a (Mouse neuroblastoma neuroblast) cells labeling QKI with Purified ab126742 at 1 : 100 dilution (5.6μg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. ab150077 Goat anti rabbit IgG(Alexa Fluor® 488) was used as the secondary antibody at 1 : 1000 dilution. DAPI nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
- WB
Unknown
Western blot - Anti-QKI antibody [EPR7306] (AB126742)
Blocking and diluting buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-QKI antibody [EPR7306] (ab126742) at 1/2000 dilution
Lane 1:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysates at 20 µg
Lane 2:
Neuro-2a (Mouse neuroblastoma neuroblast) whole cell lysates at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 37 kDa
false
- IP
Unknown
Immunoprecipitation - Anti-QKI antibody [EPR7306] (AB126742)
ab126742 (purified) at 1 : 30 dilution (2μg) immunoprecipitating QKI in HeLa whole cell lysate.
Lane 1 (input) : HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate 10μg
Lane 2 (+) : ab126742 & HeLa whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab126742 in HeLa whole cell lysate
For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366) was used for detection at 1 : 1000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-QKI antibody [EPR7306] (ab126742)
Predicted band size: 37 kDa
false
- WB
Unknown
Western blot - Anti-QKI antibody [EPR7306] (AB126742)
All lanes:
Western blot - Anti-QKI antibody [EPR7306] (ab126742) at 1/1000 dilution
Lane 1:
Neuro 2a cell lysate at 10 µg
Lane 2:
HeLa cell lysate at 10 µg
Lane 3:
K562 cell lysate at 10 µg
Secondary
All lanes:
Goat-anti-rabbit HRP at 1/2000 dilution
Predicted band size: 37 kDa
Observed band size: 38 kDa
true
- WB
Lab
Western blot - Anti-QKI antibody [EPR7306] (AB126742)
Lanes 1 - 4 : Merged signal (red and green). Green - ab126742 observed at 37 kDa. Red - loading control, ab7291, observed at 50 kDa.
ab126742 was shown to specifically react with in wild-type HAP1 cells as signal was lost in QKI knockout cells. Wild-type and QKI knockout samples were subjected to SDS-PAGE. The membrane was blocked with 3% NF Milk. ab126742 and ab7291 (Mouse anti Tubulin loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-QKI antibody [EPR7306] (ab126742) at 1/1000 dilution
Lane 1:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 2:
QKI knockout HAP1 whole cell lysate at 20 µg
Lane 3:
HeLa whole cell lysate at 20 µg
Lane 4:
THP-1 whole cell lysate at 20 µg
Predicted band size: 37 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-QKI antibody [EPR7306] (AB126742)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
QKI functions in regulating mRNA which is essential for proper cell differentiation and development. This protein is not known to be part of a larger complex but interacts with various RNA substrates and auxiliary proteins to exert its functions. QKI's actions impact neural tissue development and lipid metabolism by modulating the splicing of target RNA molecules. It also influences myelination in the nervous system by controlling key mRNAs involved in the process.
Pathways
QKI plays key roles in two important signaling pathways: the Wnt/β-catenin and the AKT signaling pathways. In the Wnt pathway QKI modulates gene expression by influencing mRNA transcripts involved in cell fate and proliferation. Through its participation in AKT signaling QKI links to proteins like PI3K and mTOR essential for cell survival and growth. These pathways illustrate QKI’s influence in both neural and systemic biological processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (30)
Recent publications for all applications. Explore the full list and refine your search
Cell death discovery 11:192 PubMed40263288
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:28323 PubMed39550498
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cell science 137: PubMed39308343
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecules and cells 47:100074 PubMed38901530
2024
Applications
Unspecified application
Species
Unspecified reactive species
Discover oncology 15:182 PubMed38782769
2024
Applications
Unspecified application
Species
Unspecified reactive species
iScience 26:108497 PubMed38213789
2024
Applications
Unspecified application
Species
Unspecified reactive species
iScience 26:108258 PubMed38026174
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell genomics 3:100303 PubMed37228754
2023
Applications
Unspecified application
Species
Unspecified reactive species
Experimental & molecular medicine 54:1024-1037 PubMed35879346
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cancer 21:145 PubMed35840974
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com